Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce

Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero Therapeutics shares rose 7.3% to $2.37 on Friday.
  • Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ:SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero Therapeutics shares rose 7.3% to $2.37 on Friday.
  • Wolfe Research cut the price target for Salesforce, Inc. (NYSE:CRM) from $200 to $180. Wolfe Research analyst Alex Zukin maintained the stock with an Outperform. Salesforce shares fell 2.6% to $146.29 on Friday.
  • Benchmark cut the price target on Omnicell, Inc. (NASDAQ:OMCL) from $170 to $157. Omnicell shares fell 0.1% to $86.22 on Friday.
  • Morgan Stanley reduced the price target for Advanced Micro Devices, Inc. (NASDAQ:AMD) from $102 to $95. AMD shares fell 1.9% to $68.17 on Friday.
  • Piper Sandler lowered the price target on Accenture plc (NYSE:ACN) from $281 to $268. Accenture shares fell 1.5% to $258.39 on Friday.
  • BMO Capital lowered the price target for The Chemours Company (NYSE:CC) from $55 to $46. Chemours shares fell 4.3% to  $25.51 on Friday.
  • RBC Capital cut the price target on AAR Corp. (NYSE:AIR) from $54 to $52. AAR shares fell 7.6% to $35.14 on Friday.

Check out this: Why Fear Level Among US Investors Is Increasing

Don’t forget to check out our premarket coverage here .

Total
0
Shares
Related Posts